NASDAQ · BLZRU
Trailblazer Acquisition Corp. Unit
$10.30+$0.01 (+0.1%)
Trailblazer Acquisition Corp. Unit’s quoted price sits in the lower half of its reported 52-week range, 6.36% below the high.
Loading market information…
NYSE · TPVG · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
TriplePoint Venture Growth BDC Corp.’s quoted price sits in the lower half of its reported 52-week range, 34.53% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
TriplePoint Venture Growth BDC Corp.’s forward annual dividend is $1.16 per share, paid quarterly. The forward yield is 25.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
TriplePoint Venture Growth BDC Corp.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $0.22. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow TriplePoint Venture Growth BDC Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 7, 2025 | $0.27-10.0% vs estimate | $21.08M-15.33% vs estimate |
|---|
| Q4 2024 | Mar 5, 2025 | $0.32-8.57% vs estimate | $2.53M-90.46% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | $0.35+2.94% vs estimate | $26.52M-1.07% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
12 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $5.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.30+$0.01 (+0.1%)
Trailblazer Acquisition Corp. Unit’s quoted price sits in the lower half of its reported 52-week range, 6.36% below the high.
$11.01-$0.45 (-3.93%)
NewtekOne, Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.83% below the high.
$11.68+$0.16 (+1.39%)
Medallion Financial Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.73% below the high.
$10.19+$0.01 (+0.05%)
GigCapital8 Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.2% below the high.
$9.15+$0.03 (+0.33%)
Chicago Atlantic BDC, Inc.’s quoted price sits in the lower half of its reported 52-week range, 18.81% below the high.
$15.90$0.00 (-4.96%)
SWK Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.17% below the high.
$3.30-$0.05 (-1.49%)
TON Strategy Co.’s quoted price sits in the upper half of its reported 52-week range, 25.68% below the high.
$16.79+$0.23 (+1.39%)
Barings Participation Investors’s quoted price sits in the lower half of its reported 52-week range, 17.05% below the high.
